Marius, from your perspective as a surgeon, what problem does this technology try to solve?

We nowadays facing major challenges in lung transplantations.

We have a shift in donor pathway, so over 50% of, uh, donors in UK are proceeding to donation after circulatory death.

This is highest in the world.

That means that the retrieval teams have very little to almost no tools to assess the lungs at the time of retrieval.

This is very different than what was, uh, traditionally the other pathway, which was donation after brain death, where the lungs were physiologically active.

You can assess, you can challenge them, you can see the gas exchange.

Could you explain why that happens and how the new technology might help change that picture, please, Marius?